Disordered lipid metabolism plays a key role in the pathogenesis of insulin resistance and type 2 diabetes. Insulin resistance, characterized by reduced responsiveness to insulin, is a major contributor to the development of type 2 diabetes. Initially, β-cells compensate for insulin resistance, but eventually, insulin deficiency leads to hyperglycemia and diabetes. Type 2 diabetes is a heterogeneous condition, with various subtypes such as maturity-onset diabetes of the young (MODY) and Donohue's syndrome. The rise in type 2 diabetes and the metabolic syndrome is attributed to sedentary lifestyles and increased energy intake. Healthy individuals primarily store excess energy as triglycerides in adipose tissue, but this can lead to ectopic lipid accumulation in the liver, skeletal muscle, and β-cells. This phenomenon is supported by studies in lipodystrophic mice, where adipose tissue transplantation or leptin replacement reduces ectopic lipid deposition and improves insulin sensitivity. Magnetic resonance spectroscopy (MRS) is a valuable tool for studying lipid and glucose metabolism. It allows for the non-invasive measurement of hepatic and muscle triglycerides, glycogen, and ATP synthesis. In healthy individuals, glucose is primarily stored as glycogen in skeletal muscle, with over 80% of infused glucose being stored as muscle glycogen during hyperglycemic-hyperinsulinemic clamps. In insulin-resistant individuals, such as type 2 diabetics and their offspring, glycogen synthesis is reduced, and glucose transport is impaired. These findings suggest that glucose transport is the rate-controlling step in insulin-stimulated glucose disposal in skeletal muscle. In the liver, insulin resistance is associated with increased gluconeogenesis and reduced glycogenolysis. Fatty acid accumulation in skeletal muscle and liver can induce insulin resistance through mechanisms involving serine phosphorylation of IRS-1, reduced tyrosine phosphorylation, and impaired PI3-kinase activation. Lipid accumulation in skeletal muscle and liver may result from increased fatty acid delivery/synthesis or mitochondrial dysfunction. Inflammation in adipose tissue, characterized by macrophage infiltration and altered cytokine production, may also contribute to insulin resistance. Recent studies suggest that inflammatory pathways, such as those involving IKK-β and JNK1, may play a role in serine phosphorylation of IRS-1. In summary, disordered lipid metabolism and mitochondrial dysfunction are key factors in the development of insulin resistance and type 2 diabetes. Understanding these mechanisms has led to new therapeutic targets for the treatment and prevention of these conditions.Disordered lipid metabolism plays a key role in the pathogenesis of insulin resistance and type 2 diabetes. Insulin resistance, characterized by reduced responsiveness to insulin, is a major contributor to the development of type 2 diabetes. Initially, β-cells compensate for insulin resistance, but eventually, insulin deficiency leads to hyperglycemia and diabetes. Type 2 diabetes is a heterogeneous condition, with various subtypes such as maturity-onset diabetes of the young (MODY) and Donohue's syndrome. The rise in type 2 diabetes and the metabolic syndrome is attributed to sedentary lifestyles and increased energy intake. Healthy individuals primarily store excess energy as triglycerides in adipose tissue, but this can lead to ectopic lipid accumulation in the liver, skeletal muscle, and β-cells. This phenomenon is supported by studies in lipodystrophic mice, where adipose tissue transplantation or leptin replacement reduces ectopic lipid deposition and improves insulin sensitivity. Magnetic resonance spectroscopy (MRS) is a valuable tool for studying lipid and glucose metabolism. It allows for the non-invasive measurement of hepatic and muscle triglycerides, glycogen, and ATP synthesis. In healthy individuals, glucose is primarily stored as glycogen in skeletal muscle, with over 80% of infused glucose being stored as muscle glycogen during hyperglycemic-hyperinsulinemic clamps. In insulin-resistant individuals, such as type 2 diabetics and their offspring, glycogen synthesis is reduced, and glucose transport is impaired. These findings suggest that glucose transport is the rate-controlling step in insulin-stimulated glucose disposal in skeletal muscle. In the liver, insulin resistance is associated with increased gluconeogenesis and reduced glycogenolysis. Fatty acid accumulation in skeletal muscle and liver can induce insulin resistance through mechanisms involving serine phosphorylation of IRS-1, reduced tyrosine phosphorylation, and impaired PI3-kinase activation. Lipid accumulation in skeletal muscle and liver may result from increased fatty acid delivery/synthesis or mitochondrial dysfunction. Inflammation in adipose tissue, characterized by macrophage infiltration and altered cytokine production, may also contribute to insulin resistance. Recent studies suggest that inflammatory pathways, such as those involving IKK-β and JNK1, may play a role in serine phosphorylation of IRS-1. In summary, disordered lipid metabolism and mitochondrial dysfunction are key factors in the development of insulin resistance and type 2 diabetes. Understanding these mechanisms has led to new therapeutic targets for the treatment and prevention of these conditions.